Entrada Therapeutics, Inc. · NASDAQ:TRDA

Dowden Nathan J had 2,528 Entrada Therapeutics, Inc. shares withheld for tax (Form 4)

Traded Sep 2, 2026 · Filed Sep 3, 2026

On Sep 2, 2026, Dowden Nathan J (President & COO) had 2,528 Entrada Therapeutics, Inc. shares withheld for tax at US$7.14 for US$18,050, leaving 196,060 shares. Filed Sep 3, 2026 (Form 4).

Withheld for tax
2,528 shares
Price
US$7.14
Value
US$18,050
Holding after
196,060 shares
Trading plan
No
Role
President & COO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 2, 2026Common StockShares withheld for tax2,528US$7.14196,060Direct

Source

View original at SEC

Related